Product

Company

NCT02200458·1 site·ClinicalTrials.gov

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Christie Medical Holdings, Inc.

This study will look at the performance capabilities of future software for VeinViewer.

Age

18–any

Sex

ALL

Healthy volunteers

Accepted

1. Presence of tattoos, scarring, and/or extensive hair in the areas to be assessed for cannulation.
2. IV cannulation in the arms or hands in the previous 4 weeks.

The record

StatusCompleted

PhaseNo phase

Taking part62

StartedNov 2012

UpdatedMar 9, 2015

Conditions

Where1

Clareo Health | Near-infrared Software Performance Study